MedPage Today January 16, 2025
— Agency also issues final rule for 6-month buprenorphine prescriptions issued over the phone
Physicians would have to register with the Drug Enforcement Administration (DEA) for telehealth prescribing of certain controlled substances under a proposed rule issued Wednesday by the agency.
“DEA’s goal is to provide telehealth access for needed medications while ensuring patient safety and preventing the diversion of medications into the illicit drug market,” DEA Administrator Anne Milgram said in a press release. “We understand the difficulties some patients have accessing medical providers in-person, and we want to ease this burden while also providing safeguards to keep patients safe.”
Under the rule, providers who prescribe Schedule III-V controlled substances would need to apply for a special registration; substances...
Today's Sponsors
Today's Sponsor